Solutions for Vaccine Innovation and Gene Therapy: Unlocking the Power of RNA

RNA technologies have revolutionized the field of therapeutics, enabling breakthroughs in vaccine development and gene therapy.

Traditional mRNA-based approaches have shown immense potential, particularly in rapid vaccine deployment and gene replacement therapies. Building upon this foundation, self-amplifying RNA (saRNA) offers a significant advantage — prolonged protein expression with lower doses, increasing efficiency and reducing costs.

In this webinar, the expert speaker will explore the evolution from standard mRNA to saRNA, highlighting the benefits of this advanced platform. She will showcase how specialized saRNA technologies provide researchers with high-quality, custom solutions that support the realization of their innovative projects. Moreover, she will share how services right from gene synthesis to saRNA production with delivery solutions caters to requirements from both clinical and research settings.

In this webinar, you will learn

Fundamentals and applications of RNA technologies.

How saRNA is advancing vaccine and gene therapy development.

The differences between standard mRNA and self-amplifying RNA.

The unique benefits of saRNA in drug development and vaccine production.

In this webinar, you will learn
Register

Webinar Details

  • Date: December 17th, 2024
  • Time: 9:00 am EDT (NA) / 2:00pm BST (UK) / 3:00pm CEST (EU-Central)
Juliana Campo Garcia Juliana Campo Garcia,

Field Application Scientist, GenScript

Juliana Campo Garcia has a background in neurobiology and immunology, where she focused on the characterization of regenerative niches in the adult brain and investigated the effects of invading immune cells on neural stem cells.
Since joining GenScript as Field Application Scientist, she has specialized in RNA and CRISPR technologies, expanding her knowledge base to provide expert technical support to customers.

Speaker-related Webinars